MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESEL- LSCHAFT MBH
发明人:
GREVE, Harald
申请号：
GEAP2012013539
公开号：
GEP201706609B
申请日:
2012.09.25
申请国别(地区):
GE
年份:
2017
代理人:
摘要：
There is represent pharmaceutical composition with improved stability for local usage at rhinitis treatment, wherein composition contains: a) Xylometazoline or physiologically acceptable salt thereof, in amount of 0.02-1.0 mass%； b) Panthenol (dexpanthenol) in amount of 0.5-8 mass%； and c) Benzalkonium chloride as conservent and/or disinfection means, in amount of 0.001-10 mass%； At that, composition stability is provided by pH-value regulation from 5.2 to 5.9 and/or by maintaining constant value by means of phosphate buffer system.
